CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Income Statement
USA - NASDAQ:CNTB - KYG235491019 - Common Stock
2.12 USD
+0.44 (+26.19%)
2.0627 USD
-0.06 (-2.7%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.08M | 26.03M | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 59.96M | 46.48M | 71.93M | 784.12M | 628.13M | |||
| Research and Development | 37.23M | 28.46M | 53.00M | 652.21M | 518.02M | |||
| Selling, General, and Administrative Expenses | 22.73M | 18.03M | 16.05M | 139.44M | 122.45M | |||
| Operating Income | -33.88M | -20.45M | -71.93M | -784.12M | -628.13M | |||
| Interest Income/Expense | 5.07M | 4.45M | 8.10M | 21.91M | -2.73M | |||
| Other Income/Expense | 2.56M | 2.59M | 1.85M | 0 | -674.27M | |||
| Non Recurring Items | null | -2.00M | 0 | -32.81M | null | |||
| Income Before Taxes | -28.25M | -15.40M | -61.99M | -795.02M | -1.31B | |||
| Income Tax | 278.00K | 223.00K | 120.00K | 2.04M | 1.70M | |||
| Net Income | -28.53M | -15.63M | -62.11M | -797.06M | -1.31B | |||
| EBITDA | -33.35M | -19.79M | -71.20M | -777.18M | -624.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.5134304768160339 | -0.2819634684512497 | -1.1232723409371932 | -14.421868679527007 | -24.939474567358857 | |||
| Non GAAP EPS | null | null | null | null | null | |||
| Statistics | ||||||||
| Profit Margin | -109.38% | -60.03% | N/A | N/A | N/A | |||
| Operating Profit Margin | -129.89% | -78.56% | N/A | N/A | N/A | |||
All data in USD